Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiaki Yagi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2021
Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesiclesYoshihiko Kakiuchi, Shinji Kuroda, Nobuhiko Kanaya, et al.
Scientific Reports|November 4, 2025
Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapyChiaki Yagi, Shinji Kuroda, Yoshihiko Kakiuchi, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STINGMasaki Sakamoto, Shinji Kuroda, Tetsuya Katayama, et al.
British Journal of Cancer|February 5, 2024
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirusMasashi Hashimoto, Shinji Kuroda, Nobuhiko Kanaya, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2021
Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesiclesYoshihiko Kakiuchi, Shinji Kuroda, Nobuhiko Kanaya, et al.
Scientific Reports|November 4, 2025
Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapyChiaki Yagi, Shinji Kuroda, Yoshihiko Kakiuchi, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STINGMasaki Sakamoto, Shinji Kuroda, Tetsuya Katayama, et al.
British Journal of Cancer|February 5, 2024
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirusMasashi Hashimoto, Shinji Kuroda, Nobuhiko Kanaya, et al.
Pageof 2